#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5053085	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 75 mg/kg, po administered twice a day for 12 consecutive days and measured on day 5	Mus musculus	2	ALA5052833	organism-based format	Patent Bioactivity Data
2.	ALA5053086	F	Antiproliferative activity against human MIA PaCa-2 cells after 72 hrs by Cell Titer Fluor assay	Homo sapiens	117	ALA5052833	cell-based format	Patent Bioactivity Data
3.	ALA5053087	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 75 mg/kg, po administered twice a day for 12 consecutive days and measured on day 3	Mus musculus	2	ALA5052833	organism-based format	Patent Bioactivity Data
4.	ALA5053088	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 75 mg/kg, po administered twice a day for 12 consecutive days and measured on day 8	Mus musculus	2	ALA5052833	organism-based format	Patent Bioactivity Data
5.	ALA5053089	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 75 mg/kg, po administered twice a day for 12 consecutive days and measured on day 10	Mus musculus	2	ALA5052833	organism-based format	Patent Bioactivity Data
6.	ALA5053090	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 75 mg/kg, po administered twice a day for 12 consecutive days and measured on day 12	Mus musculus	2	ALA5052833	organism-based format	Patent Bioactivity Data
7.	ALA5053091	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 200 mg/kg, po administered twice a day for 12 consecutive days and measured on day 3	Mus musculus	1	ALA5052833	organism-based format	Patent Bioactivity Data
8.	ALA5053092	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 200 mg/kg, po administered twice a day for 12 consecutive days and measured on day 5	Mus musculus	1	ALA5052833	organism-based format	Patent Bioactivity Data
9.	ALA5053093	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 200 mg/kg, po administered twice a day for 12 consecutive days and measured on day 8	Mus musculus	1	ALA5052833	organism-based format	Patent Bioactivity Data
10.	ALA5053094	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 200 mg/kg, po administered twice a day for 12 consecutive days and measured on day 10	Mus musculus	1	ALA5052833	organism-based format	Patent Bioactivity Data
11.	ALA5053095	F	Antitumor activity against human K562 cells xenografted female SCID Bg mouse assessed as tumor growth inhibition at 200 mg/kg, po administered twice a day for 12 consecutive days and measured on day 12	Mus musculus	1	ALA5052833	organism-based format	Patent Bioactivity Data
12.	ALA5053106	B	Stabilization of mono-ubiquitinated UBE2K (unknown origin) at 0.4 to 100 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	single protein format	Patent Bioactivity Data
13.	ALA5053107	B	Stabilization of mono-ubiquitinated UBE2K (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	single protein format	Patent Bioactivity Data
14.	ALA5053108	B	Stabilization of mono-ubiquitinated UBE2D4 (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	assay format	Patent Bioactivity Data
15.	ALA5053109	B	Stabilization of mono-ubiquitinated UBE2E1 (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	single protein format	Patent Bioactivity Data
16.	ALA5053110	B	Stabilization of mono-ubiquitinated UBE2Q2 (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	assay format	Patent Bioactivity Data
17.	ALA5053111	B	Stabilization of mono-ubiquitinated UBE2S (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	assay format	Patent Bioactivity Data
18.	ALA5053112	B	Stabilization of mono-ubiquitinated UBE2W (unknown origin) at 500 uM assessed as decrease in poly-Ub measured by poly-ubiquitination assay	Homo sapiens	3	ALA5052833	assay format	Patent Bioactivity Data
19.	ALA5053113	B	Stabilization of UBE2K (unknown origin) at 1 to 1000 uM assessed as modulation of ubiquitin discharge measured by ELISA assay	Homo sapiens	5	ALA5052833	single protein format	Patent Bioactivity Data